Company: COOT
Filing Date: 2025-10-23
Form Type: 20-F
Source: 0001493152-25-019123
Chunk: 7

Company: Australian Oilseeds Holdings Ltd
Filing Date: 2025-10-23
Form: 20-F
Item: Item 3
Chunk 7
---
 of the following may
occur, each of which could have a material adverse effect on our shareholders:

  the                                                                                                 
  the                                                                                                 
  our                                                                                                 
  the                                                                                                 
  the                                                                                                 
  the                                                                                                 
  the                                                                                                 
  the                                                                                                 

Our
principal shareholders will continue to have significant influence over the election of our board of directors and approval of any significant
corporate actions, including any sale of the Company.

Our
founders, executive officers, directors, and other principal shareholders, in the aggregate, beneficially own a majority of our outstanding
shares. These shareholders currently have, and likely will continue to have, significant influence with respect to the election of our
board of directors and approval or disapproval of all significant corporate actions. The concentrated voting power of these shareholders
could have the effect of delaying or preventing an acquisition of the Company or another significant corporate transaction.

   5  

We
could be subject to securities class action litigation.

In
the past, securities class action litigation has often been brought against companies following a decline in the market price of their
securities. In 2020, 22% of securities class action litigation filings were against defendants in the health technology and services
sector, which accounted for 22% of new filings. If we face such litigation, it could result in substantial costs and a diversion of management’s
attention and resources, which could harm our business.

If
securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, the market
price for the shares and trading volume could decline.

The
trading market for our Ordinary Shares will depend in part on the research and reports that securities or industry analysts publish about
us or our business. If research analysts do not establish and maintain adequate research coverage or if one or more of the analysts who
cover us downgrades our Ordinary Shares or publishes inaccurate or unfavorable research about our business, the market price for our
Ordinary Shares would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us
regularly, we could lose visibility in the financial markets, which, in turn, could cause the market price or trading volume for our
Ordinary Shares to decline.

We
do not expect to pay dividends in the foreseeable future, and you must rely on price appreciation of your Ordinary Shares for return
on your investment.

We
have paid no cash dividends on any class of our stock to